ENDOGENOUS REGULATION OF LEUKOTRIENE SYNTHESIS
ENDOGENOUS REGULATION OF LEUKOTRIENE SYNTHESIS
批准号:
3140579
负责人:
STEVEN J FEINMARK
金额:
$19.48万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-09-01 至 1991-08-31
关键词:
aspirin calcium cell migration chemotaxis cyclic AMP eicosanoid metabolism gas chromatography mass spectrometry high performance liquid chromatography human tissue immunomodulators immunopharmacology inflammation leukopoietic factor leukotrienes membrane channels neutrophil platelets prostacyclins prostaglandin endoperoxide synthase radioimmunoassay tissue /cell culture vascular endothelium permeability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Leukotriene (LT) C4 plays a role in broncho- and vasospasm during
anaphylaxis and asthma. This myogenic activity alone with LTC4
induction of increased vascular permeability have been implicated
in the production of the inflammatory response. LTC4 production
by endothelial cells (EC) in vitro requires an exogenous source of
the unstable precursor, LTA4. It has been shown that
polymorphonuclear leukocytes (PMNL) can provide LTA4 as
substrate for vascular cell LTC4 synthesis. Other data suggests
that prostacyclin (PG12) an EC product, can inhibit PMNL
production of LTA4. In addition, the platelet/PMNL product 5(s),
12 (s)-DHETE, a potent antagonist of LTB4-induced PMNL
activation, may also play a role by modulating PMNL responses to
LTB4.
This proposal will relate the biochemical interactions of PMNL,
vascular cells and platelets to the control of LT synthesis and
their physiologic effects. Studies have been proposed to
characterize the synthesis of eicosanoids by each cell-type alone
and during coincubations. The function of PG12 as biological
regulator of PMNL LT synthesis and existence of a feedback
control loop will be tested. The proposal that LTC4-induced
increases in EC permeability modulate PMNL migration across
intact EC monolayers will be examined. Studies will measure the
production and physiologic relevance of platelet/PMNL
cooperative metabolite (e.g. 5(s), 12(s)-DHETE) as a natural
antagonist of LTB4.
This work will be carried out using cultured vascular cells and
freshly prepared human leukocytes and platelets. Most analyses
will employ high performance liquid chromatography (HPLC) with
methods developed in this laboratory. Data will also be collected
by radioimmunoassay, enzyme immunoasay, and by gas
chromatography/mass spectrometry. Leukocyte migration studies
and electrical resistance measurements will be performed and will
use EC monolayers grown on amnion. PMNL intracellular calcium
measurements will be done in collaboration with Dr. Susan
Steinberg and will use the intracellular calcium dye, fura-2.
These novel interactions which provide a source of substrate and
biochemical modulation of local vascular LTC4 synthesis are
potentially important during the development of inflammatory
response. Smooth muscle contraction and PMNL influxes are
important in the alterations in bronchial tone during asthma or
acute hypersensitivity reactions and in the damage of myocardial
infarction. Regulation and control of PMNL migration and
vascular permeability are critical to homeostasis and in all
inflammatory reactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PMNL, PAF and KCnk3 in Cardiac Arrhythmias
-
批准号:6732751
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2003
-
负责人:STEVEN J FEINMARK
-
依托单位:
Role of PMNL, PAF and KCnk3 in Cardiac Arrhythmias
-
批准号:6572988
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2003
-
负责人:STEVEN J FEINMARK
-
依托单位:
Role of PMNL, PAF and KCnk3 in Cardiac Arrhythmias
-
批准号:7009901
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2003
-
负责人:STEVEN J FEINMARK
-
依托单位:
Role of PMNL, PAF and KCnk3 in Cardiac Arrhythmias
-
批准号:6844904
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2003
-
负责人:STEVEN J FEINMARK
-
依托单位:
REPERFUSION ARRHYTHMIAS--MECHANISMS AND PREVENTION
-
批准号:2883284
-
项目类别:
-
资助金额:$36.16万
-
财政年份:1997
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2267944
-
项目类别:
-
资助金额:$83.85万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2463267
-
项目类别:
-
资助金额:$84.24万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2267943
-
项目类别:
-
资助金额:$80.15万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:6330452
-
项目类别:
-
资助金额:$93.47万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:6477329
-
项目类别:
-
资助金额:$95.62万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:6126237
-
项目类别:
-
资助金额:$90.88万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:3100373
-
项目类别:
-
资助金额:$77.55万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2839340
-
项目类别:
-
资助金额:$86.57万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:2267942
-
项目类别:
-
资助金额:$75.62万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LIPIDS AND SIGNAL TRANSDUCTION IN NEURONS
-
批准号:3100374
-
项目类别:
-
资助金额:$72.71万
-
财政年份:1992
-
负责人:STEVEN J FEINMARK
-
依托单位:
LEUKOTRIENES AND LEUKOCYTE/VASCULAR CELL INTERACTIONS
-
批准号:3471087
-
项目类别:
-
资助金额:$11.23万
-
财政年份:1988
-
负责人:STEVEN J FEINMARK
-
依托单位:
ENDOGENOUS REGULATION OF LEUKOTRIENE SYNTHESIS
-
批准号:3140580
-
项目类别:
-
资助金额:$16.41万
-
财政年份:1988
-
负责人:STEVEN J FEINMARK
-
依托单位:
ENDOGENOUS REGULATION OF LEUKOTRIENE SYNTHESIS
-
批准号:3140581
-
项目类别:
-
资助金额:$15.63万
-
财政年份:1988
-
负责人:STEVEN J FEINMARK
-
依托单位:
LEUKOTRIENES AND LEUKOCYTE/VASCULAR CELL INTERACTIONS
-
批准号:3471084
-
项目类别:
-
资助金额:$10.03万
-
财政年份:1988
-
负责人:STEVEN J FEINMARK
-
依托单位:
LEUKOTRIENES AND LEUKOCYTE/VASCULAR CELL INTERACTIONS
-
批准号:2218792
-
项目类别:
-
资助金额:$10.37万
-
财政年份:1988
-
负责人:STEVEN J FEINMARK
-
依托单位:
国内基金
海外基金
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张明明
-
依托单位:
miR-30调控Calcium/Calcineurin通路在慢性肾脏病心肌保护中的作用
-
批准号:81670699
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:郑春霞
-
依托单位:
水稻OsCAS(Calcium-sensing Receptor)基因的功能分析
-
批准号:30900771
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:赵昕
-
依托单位: